Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134091) titled 'Study on Performance Validation of Human Cholangiocarcinoma 14-gene Variant Detection Kit' on Oct. 10.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Cholangio carcinoma
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2024-10-31
Target Sample Size: Observation group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=261955
Disclaimer: Curated by HT Syndication....